Company: FORL
Filing Date: 2025-06-11
Form Type: PRE 14A
Source: 0001213900-25-053453
Chunk: 49

Company: Four Leaf Acquisition Corp
Filing Date: 2025-06-11
Form: PRE 14A
Chunk 49
---
 to vote their shares at the Special Meeting. Interests of the Company’s Directors and Executive Officers When you consider the recommendation of the Board in favor of approval of the proposals, you should keep in mind that our Sponsor and our directors and executive officers have interests in such proposals that are different from, or in addition to, those of the stockholders and warrant holders generally. These interests include that our Sponsor, as well as our executive officers and directors will lose their entire investment if a business combination 19 is not completed (other than with respect to Class A common stock they may acquire in the future), and that our Sponsor will benefit from the completion of a business combination and may be incentivized to complete the business combination, even if it is with a less favorable target company or on less favorable terms to stockholders, rather than liquidate the Company. Additionally, among other things, these interests include the following: •the fact that our Sponsor and our directors have agreed not to redeem any common stock held by them in connection with the stockholder vote to approve a proposed initial business combination, including the business combination; •the fact that our Sponsor paid an aggregate of $25,000 for the 1,355,250 founder shares currently owned by our independent directors and Sponsor, in which certain of the our officers and directors hold a direct and indirect interest. The founder shares would be worthless if a business combination is not consummated by the Current Termination Date (assuming we do not decide to exercise the second extension option), because the holders are not entitled to participate in any redemption or distribution with respect to such shares. Such securities may have a significantly higher value at the time of the business combination and, if unrestricted and freely tradable, would be valued at approximately $[•], based upon the closing price of our Class A common stock on the Nasdaq on [•], 2025; •the fact that if a business combination is not consummated by the Current Termination Date (assuming we do not decide to exercise the currently available second three -monthextension option available under the Amended Certificate), the 3,576,900 private warrants, each exercisable to purchase one share of Class A common stock at $11.50 per share, subject to adjustment, held by our Sponsor, in which certain of our officers and directors hold a direct and indirect interest, which were acquired for an aggregate purchase price of $3,576,900 in a private placement that took place simultaneously with the consummation of the IPO. Such securities may